Menu

Search

  |   Business

Menu

  |   Business

Search

Consolidated Research: 2018 Summary Expectations for Government Properties Income Trust, Grand Canyon Education, The Chefs' Warehouse, Hemispherx BioPharma, Revlon, and Blueprint Medicines — Fundamental Analysis, Key Performance Indications

NEW YORK, March 19, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Government Properties Income Trust (NASDAQ:GOV), Grand Canyon Education, Inc. (NASDAQ:LOPE), The Chefs' Warehouse, Inc. (NASDAQ:CHEF), Hemispherx BioPharma, Inc. (NYSE:HEB), Revlon, Inc. (NYSE:REV), and Blueprint Medicines Corporation (NASDAQ:BPMC), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

GOV DOWNLOAD: http://Fundamental-Markets.com/register/?so=GOV
LOPE DOWNLOAD:
http://Fundamental-Markets.com/register/?so=LOPE
CHEF DOWNLOAD:
http://Fundamental-Markets.com/register/?so=CHEF
HEB DOWNLOAD:
http://Fundamental-Markets.com/register/?so=HEB
REV DOWNLOAD:
http://Fundamental-Markets.com/register/?so=REV
BPMC DOWNLOAD:
http://Fundamental-Markets.com/register/?so=BPMC

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Government Properties Income Trust (NASDAQ:GOV), Grand Canyon Education, Inc. (NASDAQ:LOPE), The Chefs' Warehouse, Inc. (NASDAQ:CHEF), Hemispherx BioPharma, Inc. (NYSE:HEB), Revlon, Inc. (NYSE:REV), and Blueprint Medicines Corporation (NASDAQ:BPMC) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed March 16th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

GOVERNMENT PROPERTIES INCOME TRUST (GOV) REPORT OVERVIEW

Government Properties Income Trust's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Government Properties Income Trust reported revenue of $107.17MM vs $66.03MM (up 62.31%) and basic earnings per share -$0.23 vs $0.17. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Government Properties Income Trust reported revenue of $316.53MM vs $258.18MM (up 22.60%) and basic earnings per share $0.14 vs $0.81 (down 82.72%). Government Properties Income Trust is expected to report earnings on April 26th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.56. The estimated EPS forecast for the next fiscal year is $2.02 and is expected to report on February 25th, 2019.

To read the full Government Properties Income Trust (GOV) report, download it here: http://Fundamental-Markets.com/register/?so=GOV

-----------------------------------------

GRAND CANYON EDUCATION, INC. (LOPE) REPORT OVERVIEW

Grand Canyon Education's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Grand Canyon Education reported revenue of $271.42MM vs $244.66MM (up 10.94%) and basic earnings per share $1.43 vs $1.03 (up 38.83%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Grand Canyon Education reported revenue of $974.13MM vs $873.34MM (up 11.54%) and basic earnings per share $4.31 vs $3.22 (up 33.85%). Grand Canyon Education is expected to report earnings on May 3rd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $1.12. The estimated EPS forecast for the next fiscal year is $5.16 and is expected to report on February 20th, 2019.

To read the full Grand Canyon Education, Inc. (LOPE) report, download it here: http://Fundamental-Markets.com/register/?so=LOPE

-----------------------------------------

THE CHEFS' WAREHOUSE, INC. (CHEF) REPORT OVERVIEW

The Chefs' Warehouse's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, The Chefs' Warehouse reported revenue of $357.10MM vs $342.90MM (up 4.14%) and basic earnings per share $0.36 vs $0.36 (unchanged). For the twelve months ended December 31st, 2017 vs December 31st, 2016, The Chefs' Warehouse reported revenue of $1,301.52MM vs $1,192.87MM (up 9.11%) and basic earnings per share $0.55 vs $0.12 (up 358.33%). The Chefs' Warehouse is expected to report earnings on May 8th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.05. The estimated EPS forecast for the next fiscal year is $0.91 and is expected to report on February 19th, 2019.

To read the full The Chefs' Warehouse, Inc. (CHEF) report, download it here: http://Fundamental-Markets.com/register/?so=CHEF

-----------------------------------------

HEMISPHERX BIOPHARMA, INC. (HEB) REPORT OVERVIEW

Hemispherx BioPharma's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Hemispherx BioPharma reported revenue of $0.09MM vs $0.02MM (up 309.09%) and basic earnings per share -$0.04 vs -$0.13. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Hemispherx BioPharma reported revenue of $0.09MM vs $0.13MM (down 30.83%) and basic earnings per share -$0.34 vs -$0.77. Hemispherx BioPharma is expected to report earnings on March 30th, 2018. The report will be for the fiscal period ending December 31st, 2017.

To read the full Hemispherx BioPharma, Inc. (HEB) report, download it here: http://Fundamental-Markets.com/register/?so=HEB

-----------------------------------------

REVLON, INC. (REV) REPORT OVERVIEW

Revlon's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Revlon reported revenue of $786.60MM vs $800.70MM (down 1.76%) and basic earnings per share -$1.46 vs -$0.70. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Revlon reported revenue of $2,693.70MM vs $2,334.00MM (up 15.41%) and basic earnings per share -$3.48 vs -$0.42. Revlon is expected to report earnings on May 4th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.23. The estimated EPS forecast for the next fiscal year is -$0.52 and is expected to report on March 21st, 2019.

To read the full Revlon, Inc. (REV) report, download it here: http://Fundamental-Markets.com/register/?so=REV

-----------------------------------------

BLUEPRINT MEDICINES CORPORATION (BPMC) REPORT OVERVIEW

Blueprint Medicines' Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Blueprint Medicines reported revenue of $1.63MM vs $7.69MM (down 78.83%) and basic earnings per share -$1.26 vs -$0.75. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Blueprint Medicines reported revenue of $21.43MM vs $27.77MM (down 22.85%) and basic earnings per share -$3.92 vs -$2.64. Blueprint Medicines is expected to report earnings on May 2nd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.84. The estimated EPS forecast for the next fiscal year is -$5.55 and is expected to report on February 20th, 2019.

To read the full Blueprint Medicines Corporation (BPMC) report, download it here: http://Fundamental-Markets.com/register/?so=BPMC

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.